インドにおける高齢者腫瘍学の課題:岐路に立つ
Bipinesh Sansar1, Anuj Gupta1, Ankita Chitre2
1Department of Medical Oncology, Homi Bhabha Cancer Hospital (HBCH) and Mahamana Pandit Madan Mohan Malviya Cancer Centre (MPMMCC), Varanasi, Uttar Pradesh, India.
South Asian journal of cancer
|December 22, 2025
まとめ
世界的に人口高齢化が進んでおり、専門的な高齢者腫瘍学ケアの必要性が高まっています。現在のリソースと認識は不十分であり、高齢者のがん治療における重大なギャップが浮き彫りになっています。
科学分野:
- 老年医学
- 腫瘍学
背景:
- 人口の増加セグメントが高齢化しており、専門的なヘルスケアアプローチが必要とされています。
- 特に高齢者層(60歳以上)において、がん罹患率が上昇しています。
研究 の 目的:
- 高齢者人口におけるがん負担の増加に対処すること。
- 高齢者腫瘍学ケアにおける満たされていないニーズを特定し、解決策を提案すること。
主な方法:
- 現在の高齢者腫瘍学の実践とリソース配分のレビュー。
- スクリーニング、介入、認識を含む主な課題の特定。
主要な成果:
- 専門的な高齢者腫瘍学クリニックはほとんど存在しません。
- 主な満たされていないニーズには、スクリーニングリソースの不足、検証された介入の欠如、認識の低さが含まれます。
結論:
- 高齢者腫瘍学サービスの拡大が急務です。
- 提案された解決策には、腫瘍学者に対するトレーニングの強化と、効果的な介入のための国別研究が含まれます。
関連する概念動画
Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
208
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
208
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
215
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
217
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
217
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175


